Citi raised the firm’s price target on Kenvue (KVUE) to $24.50 from $22 and keeps a Neutral rating on the shares. The company reported “better-than-feared” Q1 results, the analyst tells investors in a research note. However, the firm says the company’s Q2 “looks a bit softer” with a later start to the allergy season and continued expected destocking.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KVUE:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue